Albuterol Sulfate Inhalation Solution Recalled Nationwide for Temperature Abuse During Manufacturing
McKesson Medical-Surgical is recalling Albuterol Sulfate Inhalation Solution nationwide due to temperature deviations during manufacturing that may have compromised product quality. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a risk-of-harm respiratory medication subject to manufacturing process deviation (temperature abuse). No illnesses or injuries have been reported, but the potential for product quality compromise in a critical asthma/COPD medication justifies this severity classification.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Albuterol Sulfate Inhalation Solution 0.083% (2.5 mg/3mL) nationwide. The inhalation solution is packaged in 25 unit-dose vials and is manufactured by Nephron Pharmaceuticals Corporation (NDC 0487-9501-25).
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations involving temperature abuse during the manufacturing process. This deviation may have affected product quality or efficacy.
The affected product was distributed nationwide to healthcare facilities and pharmacies. McKesson Medical-Surgical is unable to identify specific lot numbers associated with individual customers, but has provided distribution dates to affected consignees.
No illnesses or adverse events have been reported. Patients currently using this medication should consult their pharmacist or healthcare provider about obtaining a replacement product or alternative asthma treatment.
The recalled product
- Product
- ALBUTEROL SULFATE (ALBUTEROL SULFATE)
- Brand
- ALBUTEROL SULFATE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Respiratory Medication
- Hazard
- temperature-abuse
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 0304879501003
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ALBUTEROL SULFATE
- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateAlbuterol sulfate inhalation aerosol recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- CriticalPrescription albuterol inhalers recalled nationwide due to defective valve seals
FDA (Drugs) · 2023-07-19
- HighAlbuterol Sulfate Inhalation Aerosol Recalled for Temperature Abuse During Distribution
FDA (Drugs) · 2022-06-15
- HighAlbuterol sulfate inhalation solution recalled for manufacturing temperature-abuse defect
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27